The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70029 ↗At a glance
Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, 2025. Written by Riham Rafea and 2 co-authors. Institution: Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany. Major MEDLINE topics: Nitric Oxide Synthase Type III, Nitric Oxide. Cited 12 times so far (Crossref); 157 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft.
Abstract (original language)
Nitric oxide (NO) generated by the endothelial NO synthase (eNOS) plays an essential role in the maintenance of vascular homeostasis and the prevention of vascular inflammation. There are a myriad of mechanisms that regulate the activity of the enzyme that may prove to represent interesting therapeutic opportunities. In this regard, the kinases that phosphorylate the enzyme and regulate its activity in situations linked to vascular disease seem to be particularly promising. Although the actions of NO were initially linked mainly to the activation of the guanylyl cyclase and the generation of cyclic GMP in vascular smooth muscle cells and platelets, it is now clear that NO elicits the majority of its actions via its ability to modify redox‐activated cysteine residues in a process referred to as S ‐nitrosylation. The more wide spread use of mass spectrometry to detect S ‐nitrosylated proteins has helped to identify just how large the NO sphere of influence is and just how many cellular processes are affected. It may be an old target, but the sheer impact of eNOS on vascular health really justifies a revaluation of therapeutic options to maintain and protect its activity in situations associated with a high risk of developing cardiovascular disease.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany.
- Partner Site RheinMain, German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany.
ORCID profiles: Ingrid Fleming
Funding
- Deutsche Forschungsgemeinschaft
Cite
APA
Rafea, R., Siragusa, M., & Fleming, I. (2025). The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70029
Vancouver
Rafea R, Siragusa M, Fleming I. The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70029
BibTeX
@article{Rafea2025,
author = {Rafea, Riham and Siragusa, Mauro and Fleming, Ingrid},
title = {The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70029}
}
EUVIMED